InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Meyers Michael L., Vice-Président Senior, Directeur Médical. Director active across 1 companies, notably Syndax Pharmaceuticals Inc. Cumulatively, 4 reports have been published. The latest transaction was disclosed on 31 January 2022 (J). Regulator: SEC (Form 4). All data is free.
Declarations4 total
€19,0421,714 shares@ €11.10970.0011% mcap29.5% of flow
Common Stock
SEC:0001562180-22-001078·
€19,0421,714 shares@ €11.10970.0011% mcap14.7% of flow
Common Stock
SEC:0001562180-22-001078:0·
€45,5485,900 shares@ €7.720.0025% mcap70.5% of flow
Common Stock
SEC:0001562180-22-000035·
€45,5485,900 shares@ €7.720.0025% mcap35.3% of flow
Common Stock
SEC:0001562180-22-000035:0·
4 of 4 declarations
About Meyers Michael L.
Michael L. Meyers is the Senior VP and Chief Medical Officer at Syndax Pharmaceuticals Inc. He is responsible for leading the company's medical and scientific initiatives. His expertise in biopharmaceuticals is essential for developing new treatments and innovation at Syndax.
